• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猴痘病毒毒素的结构:对药物设计的启示。

Structure of monkeypox virus poxin: implications for drug design.

机构信息

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i, Flemingovo nám. 2, 166 10, Prague 6, Czech Republic.

出版信息

Arch Virol. 2023 Jun 28;168(7):192. doi: 10.1007/s00705-023-05824-4.

DOI:10.1007/s00705-023-05824-4
PMID:37378908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10307694/
Abstract

Monkeypox, or mpox, is a disease that has recently resurfaced and spread across the globe. Despite the availability of an FDA-approved vaccine (JYNNEOS) and an effective drug (tecovirimat), concerns remain over the possible recurrence of a viral pandemic. Like any other virus, mpox virus must overcome the immune system to replicate. Viruses have evolved various strategies to overcome both innate and adaptive immunity. Poxviruses possess an unusual nuclease, poxin, which cleaves 2'-3'-cGAMP, a cyclic dinucleotide, which is an important second messenger in the cGAS-STING signaling pathway. Here, we present the crystal structure of mpox poxin. The structure reveals a conserved, predominantly β-sheet fold and highlights the high conservation of the cGAMP binding site and of the catalytic residues His17, Tyr138, and Lys142. This research suggests that poxin inhibitors could be effective against multiple poxviruses.

摘要

猴痘,或称为 mpox,是一种最近重新出现并在全球范围内传播的疾病。尽管有 FDA 批准的疫苗(JYNNEOS)和有效的药物(tecovirimat),但人们仍然担心病毒大流行可能会再次发生。与任何其他病毒一样,mpox 病毒必须克服免疫系统才能复制。病毒已经进化出各种策略来克服先天和适应性免疫。痘病毒具有一种不寻常的核酸酶,即 poxin,它可以切割 2'-3'-cGAMP,一种环状二核苷酸,它是 cGAS-STING 信号通路中的重要第二信使。在这里,我们展示了 mpox poxin 的晶体结构。该结构揭示了一个保守的、主要是 β-折叠结构,并突出了 cGAMP 结合位点和催化残基 His17、Tyr138 和 Lys142 的高度保守性。这项研究表明,poxin 抑制剂可能对多种痘病毒有效。

相似文献

1
Structure of monkeypox virus poxin: implications for drug design.猴痘病毒毒素的结构:对药物设计的启示。
Arch Virol. 2023 Jun 28;168(7):192. doi: 10.1007/s00705-023-05824-4.
2
Structures of diverse poxin cGAMP nucleases reveal a widespread role for cGAS-STING evasion in host-pathogen conflict.多种 poxin cGAMP 核酸酶的结构揭示了 cGAS-STING 逃避在宿主-病原体冲突中的广泛作用。
Elife. 2020 Nov 16;9:e59753. doi: 10.7554/eLife.59753.
3
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.人类正痘病毒感染的治疗策略:猴痘(mpox)、天花、软疣痘和羊痘。
Travel Med Infect Dis. 2023 Mar-Apr;52:102528. doi: 10.1016/j.tmaid.2022.102528. Epub 2022 Dec 17.
4
Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.猴痘(mpox)病毒蛋白酶与 FDA 批准的先导分子的分子对接。
J Infect Public Health. 2023 May;16(5):784-791. doi: 10.1016/j.jiph.2023.03.004. Epub 2023 Mar 7.
5
Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: Structural basis of their function.氟化 cGAMP 类似物可作为 STING 激动剂,并且不能被痘病毒裂解:它们功能的结构基础。
Structure. 2024 Apr 4;32(4):433-439.e4. doi: 10.1016/j.str.2024.01.008. Epub 2024 Feb 6.
6
Human monkeypox virus in the shadow of the COVID-19 pandemic.人类猴痘病毒在 COVID-19 大流行的阴影下。
J Infect Public Health. 2023 Aug;16(8):1149-1157. doi: 10.1016/j.jiph.2023.05.013. Epub 2023 May 13.
7
Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.新冠疫情期间的猴痘疫情——过去与未来
J Med Virol. 2023 Apr;95(4):e28701. doi: 10.1002/jmv.28701.
8
Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.在非人类灵长类动物中联合使用特考韦瑞玛特和 ACAM2000TM:特考韦瑞玛特治疗对 ACAM2000 免疫原性和针对致死性猴痘病毒攻击的疗效的影响。
Vaccine. 2020 Jan 16;38(3):644-654. doi: 10.1016/j.vaccine.2019.10.049. Epub 2019 Oct 31.
9
Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape.先天性免疫对猴痘病毒感染的反应:机制与免疫逃避。
J Innate Immun. 2024;16(1):413-424. doi: 10.1159/000540815. Epub 2024 Aug 13.
10
Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.2022 年 5 月至 2023 年 5 月,加利福尼亚州,接受 JYNNEOS 疫苗接种者感染猴痘相关住院的几率降低。
MMWR Morb Mortal Wkly Rep. 2023 Sep 8;72(36):992-996. doi: 10.15585/mmwr.mm7236a4.

引用本文的文献

1
Evaluating the Antiviral Potential of Polyherbal Formulation () Against Monkeypox Virus: Targeting E5, Poxin, and DNA Polymerase Through Multifaceted Drug Discovery Approaches.评估多草药配方()对猴痘病毒的抗病毒潜力:通过多方面药物发现方法靶向E5、痘毒素和DNA聚合酶。
Life (Basel). 2025 May 12;15(5):771. doi: 10.3390/life15050771.
2
Mpox virus poxin-schlafen fusion protein suppresses innate antiviral response by sequestering STAT2.猴痘病毒痘蛋白-睡眠蛋白融合蛋白通过隔离信号转导和转录激活因子2(STAT2)来抑制先天性抗病毒反应。
Emerg Microbes Infect. 2025 Dec;14(1):2477639. doi: 10.1080/22221751.2025.2477639. Epub 2025 Mar 18.
3

本文引用的文献

1
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase.猴痘病毒甲基转移酶 VP39 抑制剂的发现和结构特征揭示了与 SARS-CoV-2 nsp14 甲基转移酶的相似性。
Nat Commun. 2023 Apr 20;14(1):2259. doi: 10.1038/s41467-023-38019-1.
2
SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.SS148 和 WZ16 抑制来自所有七种人致病性冠状病毒的 nsp10-nsp16 复合物的活性。
Biochim Biophys Acta Gen Subj. 2023 Apr;1867(4):130319. doi: 10.1016/j.bbagen.2023.130319. Epub 2023 Feb 9.
3
The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era.
猴痘的再度流行:天花根除后时代的流行病学、临床特征及公共卫生影响
New Microbes New Infect. 2024 Sep 24;62:101487. doi: 10.1016/j.nmni.2024.101487. eCollection 2024 Dec.
microRNAs-based diagnostic and therapeutic applications in liver fibrosis.
基于 microRNAs 的肝纤维化诊断和治疗应用。
Wiley Interdiscip Rev RNA. 2023 Jul-Aug;14(4):e1773. doi: 10.1002/wrna.1773. Epub 2022 Dec 30.
4
New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus.新型抗菌药物:特考韦瑞用于治疗人类猴痘病毒。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0122622. doi: 10.1128/aac.01226-22. Epub 2022 Nov 14.
5
Monkeypox.猴痘
N Engl J Med. 2022 Nov 10;387(19):1783-1793. doi: 10.1056/NEJMra2208860. Epub 2022 Oct 26.
6
Novel Poxin Stable cGAMP-Derivatives Are Remarkable STING Agonists.新型 Poxin 稳定 cGAMP 衍生物是卓越的 STING 激动剂。
Angew Chem Int Ed Engl. 2022 Oct 4;61(40):e202207175. doi: 10.1002/anie.202207175. Epub 2022 Aug 31.
7
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.发现具有免疫调节潜力的同核苷型环状二核苷酸作为有效的 STING 激动剂。
Structure. 2022 Aug 4;30(8):1146-1156.e11. doi: 10.1016/j.str.2022.05.012. Epub 2022 Jun 10.
8
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.使用 JYNNEOS(天花和猴痘疫苗,活病毒,非复制)对有职业性接触正痘病毒风险的人员进行暴露前疫苗接种:免疫实践咨询委员会的建议-美国,2022 年。
MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-742. doi: 10.15585/mmwr.mm7122e1.
9
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.利纳卡帕韦治疗多种药物耐药 HIV-1 感染时对衣壳的抑制作用。
N Engl J Med. 2022 May 12;386(19):1793-1803. doi: 10.1056/NEJMoa2115542.
10
A Helquat-like Compound as a Potent Inhibitor of Flaviviral and Coronaviral Polymerases.一种类 Helquat 化合物作为黄病毒和冠状病毒聚合酶的有效抑制剂。
Molecules. 2022 Mar 15;27(6):1894. doi: 10.3390/molecules27061894.